IMMUNE NETWORK

  • 제11권3호
  • /
  • Pages.175-181
  • /
  • 2011
  • /
  • 1598-2629(pISSN)
  • /
  • 2092-6685(eISSN)
대한면역학회 (The Korean Association of Immunobiologists)
권호 표지
DOI QR코드

DOI QR Code

Identification of CM1 as a Pathogenic Factor in Inflammatory Diseases and Cancer

  • Bae, Se-Yeon (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Kim, Hyem-In (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Yu, Yeon-Sil (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Lee, Na-Eun (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Kong, Joo-Myoung (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Kim, Hang-Rae (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Hwang, Young-Il (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Song, Yeong-Wook (Department of Internal Medicine, Medical Research Center, Seoul National University College of Medicine) ;
  • Kang, Jae-Seung (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine) ;
  • Lee, Wang-Jae (Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine)
  • 투고 : 2011.06.01
  • 심사 : 2011.06.14
  • 발행 : 2011.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: CM1 (centrocyte/-blast marker 1) was defined by a mAb against concavabalin-A (ConA) activated PBMC. It is expressed in germinal center of human tonsil and on the surface of activated PBMC as well as cancer cells. Recently, increased productions of pro-inflammatory mediators were detected from activated PBMC by CM1 ligation. Methods: However, there is a limitation to explain the exact role of CM1 on inflammation and its related mechanisms, since the identity of CM1 is still not clarified. In our previous study, we have already confirmed that soluble form of CM1 was produced by Raji. Therefore, we performed Q-TOF analysis after immunoprecipitation of concentrated Raji culture supernatant using anti-CM1 mAbs. Results: As a result, we found that CM1 is identical to enolase-1(ENO1), a glycolytic enzyme, and we confirmed that results by silencing ENO1 using siRNA. It was also confirmed through competition assay between anti-CM1 and anti-ENO1 mAbs. Finally, we investigated the possible role of CM1 in inflammatory response and cancer. The ligation of CM1 on Raji cells with anti-CM1 mAbs induces the extensive production of prostaglandin $E_2(PGE_2)$. In addition, the increased activity of matrix metalloproteinase (MMP)-2/9 was shown in NCI-N87, stomach cancer cell line by CM1 stimulation. Conclusion: CM1 is identical to ENO1 and it might be an important role in the regulation of inflammatory responses.

키워드

참고문헌

  1. Hur DY, Kim S, Kim YI, Min HY, Kim DJ, Lee DS, Cho D, Hwang YI, Hwang DH, Park SH, Ahn HK, Chang KY, Kim YB, Lee WJ: CM1, a possible novel activation molecule on human lymphocytes. Immunol Lett 74;95-102, 2000 https://doi.org/10.1016/S0165-2478(00)00201-7
  2. Kang JS, Kim D, Kim YI, Lee WJ, Chang KY: Development of tumor screening ELISA kit by using novel tumor antigen, CM1. Immune Netw 5;124-128, 2005 https://doi.org/10.4110/in.2005.5.2.124
  3. Lee YS, Kim YS, Kim D, Hur DY, Kang JS, Kim YI, Hahm ES, Cho DH, Hwang YI, Lee WJ: CM1 ligation induces apoptosis via Fas-FasL interaction in Ramos cells, but via down-regulation of Bcl-2 and subsequent decrease of mitochondrial membrane potential in Raji cells. Immune Netw 6;59-66, 2006 https://doi.org/10.4110/in.2006.6.2.59
  4. Kim D, Hur DY, Kim YS, Lee K, Lee Y, Cho D, Kang JS, Kim YI, Hahm E, Yang Y, Yoon S, Kim S, Lee WB, Park HY, Kim YB, Hwang YI, Chang KY, Lee WJ: CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells. Hum Immunol 63;576-587, 2002 https://doi.org/10.1016/S0198-8859(02)00405-6
  5. Kim YS, Park GB, Choi YM, Kwon OS, Song HK, Kang JS, Kim YI, Lee WJ, Hur DY: Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner. Hum Immunol 67;795-807, 2006 https://doi.org/10.1016/j.humimm.2006.07.008
  6. Marin JM, Gracia-Lor E, Sancho JV, Lopez FJ, Hernández F: Application of ultra-high-pressure liquid chromatography- tandem mass spectrometry to the determination of multi-class pesticides in environmental and wastewater samples. Study of matrix effects. J Chromatogr A 1216; 1410-1420, 2009 https://doi.org/10.1016/j.chroma.2008.12.094
  7. Petrovic M, Gros M, Barcelo D: Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. J Chromatogr A 1124;68-81, 2006 https://doi.org/10.1016/j.chroma.2006.05.024
  8. Pancholi V: Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 58;902-920, 2001 https://doi.org/10.1007/PL00000910
  9. Giallongo A, Feo S, Showe LC, Croce CM: Isolation and partial characterization of a 48-kDa protein which is induced in normal lymphocytes upon mitogenic stimulation. Biochem Biophys Res Commun 134;1238-1244, 1986 https://doi.org/10.1016/0006-291X(86)90383-9
  10. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF: Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30;1682-1691, 1991 https://doi.org/10.1021/bi00220a034
  11. Redlitz A, Fowler BJ, Plow EF, Miles LA: The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 227;407-415, 1995 https://doi.org/10.1111/j.1432-1033.1995.tb20403.x
  12. Lopez-Alemany R, Longstaff C, Hawley S, Mirshahi M, Fabregas P, Jardi M, Merton E, Miles LA, Felez J: Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. Am J Hematol 72; 234-242, 2003 https://doi.org/10.1002/ajh.10299
  13. Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P: Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol 27;109-115, 2000
  14. Li J, Ny A, Leonardsson G, Nandakumar KS, Holmdahl R, Ny T: The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol 166;783-792, 2005 https://doi.org/10.1016/S0002-9440(10)62299-7